PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage

NCT02918747 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: pegaspargase
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Dexamethasone
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
RADIATION: IMRT

Sponsor

Hunan Cancer Hospital